Evidence map›Paper›PMID 42873371›Full record

ArticleDiscover nano2026

Eco-friendly synthesis and multifunctional characterization of ZrO

Adnan Alnehia, M A Ahlam, Muhammad Hadi

Abstract read
In one paragraph

Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adnan AlnehiaDepartment of Physics, Faculty of Applied Sciences, Thamar University, Dhamar, 87246, Yemen. adnanalnahia83@gmail.com.
M A AhlamDepartment of Physics, College of Science, Qassim University, Buraydah, 51452, Saudi Arabia.
Muhammad HadiDepartment of Physics, Faculty of Sciences, King Khalid University, P.O.Box 9004, Abha, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study presents a simple chemical co-precipitation method for synthesizing a multifunctional ZrO2/Cu4O3/MnO2/CuMnO2 nanocomposite, utilizing distilled water as the reaction solvent and an eco-friendly medium, followed by thermal treatment at 500 °C for 2 h. This aqueous-based process allows precise control over the synthesis of a hybrid metal-oxide system, enhancing its thermal and functional properties.

methodsComprehensive characterization was performed using X-ray diffraction (XRD), scanning electron microscopy (SEM) coupled with energy dispersive X-ray spectroscopy (EDX), transmission electron microscopy (TEM), thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FTIR), and ultraviolet-visible spectroscopy (UV-Vis).

resultsXRD results showed well-crystallized phases with average particle sizes in the nanometer range, while EDX revealed uniform elemental distribution without detectable impurities. The nanocomposite exhibits a direct optical band gap of approximately 2.97 eV and strong absorption in the UV-Vis region, indicating semiconductor behavior. Thermogravimetric analysis confirmed high thermal stability up to elevated temperatures. Additionally, the nanocomposite demonstrated strong antibacterial activity against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), with inhibition zones reaching up to 18 mm.

conclusionThe combination of high thermal stability, suitable optical properties, and robust antibacterial performance suggests the potential of this new nanocomposite for applications such as antimicrobial coatings and other multifunctional electronic materials.

Indexed as

AntibacterialBandgapNanocompositeZrO2/Cu4O3/MnO2/CuMnO2

Identifiers

PMID42873371
PMCPMC13669264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.